Clinical Trial Update: Trastuzumab and Flavopiridol in Treating Patients With Metastatic Breast Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial of trastuzumab with flavopiridol in metastatic breast cancer, including HER2-positive and male breast cancer, has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Male Breast Cancer

Drugs mentioned

• Flavopiridol (alvocidib)
• Trastuzumab (trastuzumab)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: HER2-positive Breast Cancer, Male Breast Cancer | Phase 1 | Status: TERMINATED